GlaxoSmithKline gets regulatory nod for wider use of ovarian cancer drug Zejula

111111111

October 24, 2019 0 Comments
GlaxoSmithKline said U.S. regulators had approved its ovarian cancer treatment Zejula for wider use in some advanced cancers.
Tags:
Share: